Crown Reserve Acquisition Corp. I Class A Ordinary Shares (CRAC)
NASDAQ (NMS) NASDAQ (NMS) Primary Summary
Crown Reserve Acquisition Corp. I Class A Ordinary Shares Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Daniel L. Lippincott Karpus Management Inc. | 807,325 | $8.08M | $8.19M | $104,952.49 | 1.3% |
| SK Steven Katznelson Radcliffe Capital Management LP | 350,000 | $3.48M | $3.55M | $70,000 | 2.01% |
| BO Brian Oliveira Clear Street Group Inc. | 256,628 | $2.56M | $2.6M | $45,918.16 | 1.8% |
Crown Reserve Acquisition Corp. I Class A Ordinary Shares (CRAC) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Crown Reserve Acquisition Corp. I Class A Ordinary Shares ever had a stock split?
Crown Reserve Acquisition Corp. I Class A Ordinary Shares Profile
| Trading Companies & Distributors Industry | Industrials Sector | Prashant Patel CEO | NASDAQ (NMS) Exchange | G2574F101 CUSIP |
| KY Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
This blank-check SPAC, incorporated in the Cayman Islands on April 29, 2025, seeks to harness capital for the purpose of executing mergers or acquisitions specifically within the healthcare industry. The focus areas encompass a variety of sectors that play crucial roles in healthcare, including pharmaceuticals, medical technology (med-tech), medical equipment, and healthcare IT solutions. By targeting these sectors, the SPAC aims to foster growth and innovation, leveraging strategic investments to enhance healthcare delivery and improve patient outcomes.
Products and Services
- Pharmaceuticals
Investments in pharmaceutical companies aimed at developing innovative drugs and therapies that address unmet medical needs. This includes both small molecule compounds and biologics, focusing on areas such as oncology, autoimmune diseases, and rare disorders.
- Med-Tech Solutions
Acquisitions of cutting-edge medical technologies that enhance the capabilities of healthcare providers. This service includes products such as surgical instruments, diagnostic devices, and advanced imaging technologies that improve procedural outcomes and patient safety.
- Medical Equipment
Targeting companies that manufacture essential medical equipment such as hospital infrastructure, diagnostic machines, and life-support systems. These investments aim to upgrade operational efficiency and healthcare delivery across various clinical settings.
- Healthcare IT
Focusing on the burgeoning field of healthcare information technology. Investments here involve software and data solutions that streamline operations, enhance patient management systems, and implement electronic health records (EHR) to foster a digitally-enabled healthcare environment.
